These data bring new information regarding molecular mechanisms under the control of both MUC4 and ErbB2 that will have to be taken into account for developing efficient targeting of both proteins in order to slow down/stop pancreatic tumour development. This evidence concerns the gene MUC4 and pancreatic neoplasm.